Discordant disability data in multiple sclerosis phase 3 studies among sphingosine-1- receptor modulator drugs

Publication date: November 2020Source: Multiple Sclerosis and Related Disorders, Volume 46Author(s): Jagannadha Avasarala

Source: Multiple Sclerosis and Related Disorders - October 1, 2020 Category: Neurology Source Type: research